Polycythemia vera

Polycythemia vera (PV) is an acquired myeloproliferative disorder characterized by an elevated absolute red blood cell mass caused by uncontrolled red blood cell production, frequently associated with uncontrolled white blood cell and platelet production.

Thrombocytosis

Increased numbers of platelets in the peripheral blood.


Total: 17

                       


(per page)
PMID (PMCID)
28259826
 MALE Middle Aged
Medical Management of Extensive Arterial Thromboembolism in a Patient with Essential Thrombocythemia and Warfarin Failure.
Ahmed AK, Youssef A, Skeik N.
Ann Vasc Surg. 2017;42:306.e5-306.e10.
This group of disorders include essential thrombocythemia (ET), polycythemia vera (PV), chronic myeloid leukemia, and primary myelofibrosis (PMF), with the respective features of thrombocytosis, erythrocytosis, and bone marrow fibrosis.
28860447
(5590514)
 MALE Middle Aged
Recurrent Cardiovascular Events Despite Antiplatelet Therapy in a Patient with Polycythemia Vera and Accelerated Platelet Turnover.
Pedersen OH, Larsen ML, Kristensen SD, Hvas AM, Grove EL.
Am J Case Rep. 2017;18:945-948.
CASE REPORT We present the case of a 58-year-old man with polycythemia vera and concomitant thrombocytosis who suffered 6 episodes of cerebral infarctions and 1 myocardial infarction, despite treatment with clopidogrel.
22157736
 MIXED_SAMPLE Adult
How to manage polycythemia vera.
Passamonti F.
Leukemia. 2012;26(5):870-4.
In the case of a patient with erythrocytosis and other signs of myeloproliferation, such as leukocytosis, thrombocytosis or splenomegaly, the diagnosis of polycythemia vera (PV) is likely, and I test serum erythropoietin and JAK2 mutations first.
21393910
 MALE Infant
Childhood acute erythroleukemia diagnosis by flow cytometry.
Sharma A, Buxi G, Walia R, Yadav RB, Sharma S.
Indian J Pathol Microbiol. 2011;54(1):173-5.
Flow cytometry can be comprehensive enough to completely subtype cases of leukemias/myelodysplastic syndromes, polycythemia rubra vera, non-neoplastic conditions like reactive erythroid hyperplasia following immunosuppressive therapy or viral infections or nutritional deficiencies, unlyzed RBCs or thrombocytosis which may mimic acute erythroid leukemia on flow cytometry.
16804363
 MIXED_SAMPLE
Leg ulcers in elderly on hydroxyurea: a single center experience in Ph- myeloproliferative disorders and review of literature.
Ruzzon E, Randi ML, Tezza F, Luzzatto G, Scandellari R, Fabris F.
Aging Clin Exp Res. 2006;18(3):187-90.
Hydroxyurea (HU) is effective in controlling thrombocytosis while reducing the risk of thrombosis in essential thrombocythemia (ET), polycythemia vera (PV) and myelofibrosis (MF).
12574969
 MALE
Cyclic thrombocytopenia and polycythemia vera.
Kojima K, Fujii N, Omoto E, Nose S, Yoneyama M, Sugii Y, Hiramatsu H, Chikatsune M, Sato M, Takata S, Itoshima T, Tanimoto M.
Ann Hematol. 2003;82(1):61-3.
We describe an unusual case of polycythemia vera in which the episodes of thrombocytopenia were followed regularly by thrombocytosis.
12508968
 MALE
Pseudohyperkalemia occurring in a patient with chronic renal failure and polycythemia vera without severe leukocytosis or thrombocytosis.
Fukasawa H, Furuya R, Kato A, Yonemura K, Fujigaki Y, Yamamoto T, Hishida A.
Clin Nephrol. 2002;58(6):451-4.
We report a case of pseudohyperkalemia in a patient with chronic renal failure and polycythemia vera without the finding of severe leukocytosis or thrombocytosis (white blood cell count 1.88 x 10(4)/microl and platelet count 37.9 x 10(4)/microl, respectively).
12508968
 MALE
Pseudohyperkalemia occurring in a patient with chronic renal failure and polycythemia vera without severe leukocytosis or thrombocytosis.
Fukasawa H, Furuya R, Kato A, Yonemura K, Fujigaki Y, Yamamoto T, Hishida A.
Clin Nephrol. 2002;58(6):451-4.
Pseudohyperkalemia occurring in a patient with chronic renal failure and polycythemia vera without severe leukocytosis or thrombocytosis.
8492422
 MALE
[Coexistence of essential thrombocythemia and gastric cancer].
Kondo H, Sakai Y, Takaso T.
Rinsho Ketsueki. 1993;34(2):224-8.
Among diagnostic criteria for ET established by the polycythemia vera study group, there is a category "No known cause for reactive thrombocytosis."
8285117
 MALE Middle Aged
[Essential thrombocythemia. Apropos a case of cerebrovascular stroke].
Oliveira AS, Miranda MP, Duarte PC, Sarmento JN.
Acta Med Port. 1993;6(10):461-5.
Additional studies confirmed the diagnosis of essential thrombocythemia, meeting all the criteria proposed by the Polycythemia Vera Study Group in 1986, after exclusion of the possible causes of reactive thrombocytosis.
1820502
 MALE Adult
[T lymphoma of immature phenotype associated with polycythemia vera].
Kurchan A, Somoza N, Pascuccelli H, Mide S, Padros MR, Santiago J, Satz ML, Fainboim L.
Medicina (B Aires). 1991;51(2):151-4.
In addition, the patient showed erythrocytosis, arterial O2 saturation of 92% and thrombocytosis, characteristics of polycythemia vera.
2716205
 FEMALE Middle Aged
[Clinical evaluation of the control of antiplatelet therapy through platelet aggregation rate on polycythemia vera associated with thrombocytosis and erythromelalgia].
Kurihara A, Kobayashi I, Tamura K.
Rinsho Ketsueki. 1989;30(1):99-104.
[Clinical evaluation of the control of antiplatelet therapy through platelet aggregation rate on polycythemia vera associated with thrombocytosis and erythromelalgia].
2716205
 FEMALE Middle Aged
[Clinical evaluation of the control of antiplatelet therapy through platelet aggregation rate on polycythemia vera associated with thrombocytosis and erythromelalgia].
Kurihara A, Kobayashi I, Tamura K.
Rinsho Ketsueki. 1989;30(1):99-104.
A 60-years-old woman with polycythemia vera with marked thrombocytosis and intolerable erythromelalgia was presented.
7221649
 FEMALE Middle Aged
Sickle cell thalassemia, thrombocytosis, and erythrocytosis.
Castro O.
South Med J. 1981;74(3):380-1.
A patient with sickle cell beta+-thalassemia had thrombocytosis and erythrocytosis due to a myeloproliferative disorder best classified as polycythemia vera.
1069602
 FEMALE Adult
Erythroleukemia-like syndrome due to busulfan toxicity in polycythemia vera.
Pezzimenti JF, Kim HC, Lindenbaum J.
Cancer. 1976;38(6):2242-6.
Over a 19-year period, a patient with polycythemia vera who had undergone a splenectomy received six courses of busulfan for recurrent thrombocytosis.
1019658
 MALE
Multiple myeloma on polycythemia vera following radioactive phosphorus therapy.
West WO.
South Med J. 1976;69(11):1516-7.
One might consider a probably less mutagenic drug such as hydroxyurea in patients with polycythemia vera when phlebotomy alone does not give good control of red cell mass and thrombocytosis.
1198693
 MALE Middle Aged
Successful control of life-threatening thrombocytosis with a blood processor.
Greenberg BR, Watson-Williams EJ.
Transfusion. 1975;15(6):620-2.
A patient with polycythemia rubra vera developed marked thrombocytosis and hemorrhage after splenectomy.